Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Bicalutamide Therapy in Young Women With NAFLD and PCOS — Stella

Home/NAFLD/Bicalutamide Therapy in Young Women With NAFLD and PCOS

View on ClinicalTrials.gov

Recruiting

Back to NAFLD trials

Bicalutamide Therapy in Young Women With NAFLD and PCOS

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

University of California San Francisco, San Francisco, California

Key details

Phase

Early testing

Sponsor

University of California, San Francisco

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Enrollment target

~50 participants

Started

February 2024

Primary completion

August 2028

Age range

18 Years – 42 Years

Sex

Female only

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.